Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 21 for PAZOPANIB
  1. Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... the intestines, heart problems, and slow wound healing. Pazopanib (Votrient ® ) Pazopanib is another drug that blocks several tyrosine kinases ...
  3. ... in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), axitinib (Inlyta ® ), ... Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other types of ...
  4. Snapshot of Adolescent and Young Adult Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly ... preoperative chemoradiation or radiation therapy with and without pazopanib , a targeted therapy that inhibits multiple enzymes involved ...
  5. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Kidney cancer: Bevacizumab (Avastin®) , sorafenib (Nexavar®) , sunitinib (Sutent®) , pazopanib (Votrient®) , temsirolimus (Torisel®) , everolimus (Afinitor®) , axitinib (Inlyta®) Leukemia: ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Pamidronate Disodium Panitumumab Panobinostat Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon Alfa-2b PEG-Intron (Peginterferon ...
  7. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is approved for ... for both kidney cancer and neuroendocrine tumors, and pazopanib for kidney cancer. Researchers are exploring the use ...
  8. ... grow beyond a certain size. Bevacizumab (Avastin ® ) and pazopanib (Votrient ® ) are examples of drugs that target blood ...
  9. ... be used alone or with more traditional chemotherapy. Pazopanib is a type of targeted therapy drug that ...
  10. ... nilotinib (Tasigna) and dasatinib (Sprycel) in chordoma, and pazopanib (Votrient ® ), everolimus (Afinitor ® ), and vismodegib (GDC-0449) in ...
previous · 1 · 2 · 3 · next